Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease.

[1]  N. Dahms,et al.  Domain 5 of the cation-independent mannose 6-phosphate receptor preferentially binds phosphodiesters (mannose 6-phosphate N-acetylglucosamine ester). , 2007, Biochemistry.

[2]  Kate Zhang,et al.  N-glycans of recombinant human acid α-glucosidase expressed in the milk of transgenic rabbits , 2007 .

[3]  B. Byrne,et al.  Recombinant human acid α-glucosidase , 2007, Neurology.

[4]  Kate Zhang,et al.  N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits. , 2007, Glycobiology.

[5]  B. Byrne,et al.  Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. , 2007, Neurology.

[6]  E. Ralston,et al.  Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  B. Thurberg,et al.  Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe disease , 2006, Laboratory Investigation.

[8]  G. Herman,et al.  Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease. , 2006, The Journal of pediatrics.

[9]  M. Rennie,et al.  How nutrition and exercise maintain the human musculoskeletal mass , 2006, Journal of anatomy.

[10]  N. Raben,et al.  Carbohydrate-remodelled acid alpha-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice. , 2005, The Biochemical journal.

[11]  R. Moreland,et al.  Lysosomal Acid α-Glucosidase Consists of Four Different Peptides Processed from a Single Chain Precursor* , 2005, Journal of Biological Chemistry.

[12]  B. Thurberg,et al.  High-resolution Light Microscopy (HRLM) and Digital Analysis of Pompe Disease Pathology , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  K. Nagashima,et al.  Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  Qun Zhou,et al.  Conjugation of Mannose 6-Phosphate-containing Oligosaccharides to Acid α-Glucosidase Improves the Clearance of Glycogen in Pompe Mice* , 2004, Journal of Biological Chemistry.

[15]  R. Howell,et al.  Pompe disease in infants and children. , 2004, The Journal of pediatrics.

[16]  W. Hop,et al.  Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human -Glucosidase From Milk , 2004 .

[17]  W. Hop,et al.  Enzyme replacement therapy in late‐onset Pompe's disease: A three‐year follow‐up , 2004, Annals of neurology.

[18]  W. Hop,et al.  Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. , 2004, Pediatrics.

[19]  N. Raben,et al.  Enzyme replacement therapy in the mouse model of Pompe disease. , 2003, Molecular genetics and metabolism.

[20]  S. Kornfeld,et al.  Mannose 6-phosphate receptors: new twists in the tale , 2003, Nature Reviews Molecular Cell Biology.

[21]  Qun Zhou,et al.  Mannose 6-phosphate quantitation in glycoproteins using high-pH anion-exchange chromatography with pulsed amperometric detection. , 2002, Analytical biochemistry.

[22]  B. Byrne,et al.  Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). , 2002, Current molecular medicine.

[23]  J. Charrow,et al.  Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial , 2001, Genetics in Medicine.

[24]  A. Vulto,et al.  Recombinant human α-glucosidase from rabbit milk in Pompe patients , 2000, The Lancet.

[25]  A. Reuser,et al.  Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. , 2000, Lancet.

[26]  A. Reuser,et al.  Recombinant Human Acid α-Glucosidase: High Level Production in Mouse Milk, Biochemical Characteristics, Correction of Enzyme Deficiency in GSDII KO Mice , 1998 .

[27]  N. Raben,et al.  Targeted Disruption of the Acid α-Glucosidase Gene in Mice Causes an Illness with Critical Features of Both Infantile and Adult Human Glycogen Storage Disease Type II* , 1998, The Journal of Biological Chemistry.

[28]  Yuan-Tsong Chen,et al.  Recombinant Human Acid α-Glucosidase Corrects Acidα-Glucosidase-Deficient Human Fibroblasts, Quail Fibroblasts, and Quail Myoblasts , 1998, Pediatric Research.

[29]  J. V. Van Hove,et al.  Recombinant human acid alpha-glucosidase corrects acid alpha-glucosidase-deficient human fibroblasts, quail fibroblasts, and quail myoblasts. , 1998, Pediatric research.

[30]  D. Chadalavada,et al.  Purification and biochemical characterisation of human placental acid α‐glucosidase , 1997 .

[31]  D. Chadalavada,et al.  Purification and biochemical characterisation of human placental acid alpha-glucosidase. , 1997, Biochemistry and molecular biology international.

[32]  A. Reuser,et al.  Isolation and Characterisation of a Recombinant, Precursor form of Lysosomal Acid α‐Glucosidase , 1995 .

[33]  A. Reuser,et al.  Isolation and characterisation of a recombinant, precursor form of lysosomal acid alpha-glucosidase. , 1995, European journal of biochemistry.

[34]  J. van Beeumen,et al.  Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation. , 1993, The Journal of biological chemistry.

[35]  A. Reuser,et al.  Use of a monoclonal antibody to distinguish between precursor and mature forms of human lysosomal alpha-glucosidase. , 1984, European journal of biochemistry.

[36]  A. Varki,et al.  The spectrum of anionic oligosaccharides released by endo-beta-N-acetylglucosaminidase H from glycoproteins. Structural studies and interactions with the phosphomannosyl receptor. , 1983, The Journal of biological chemistry.

[37]  H. Galjaard,et al.  Biochemical, immunological, and cell genetic studies in glycogenosis type II. , 1978, American journal of human genetics.

[38]  T. de Barsy,et al.  Enzyme replacement in Pompe disease: an attempt with purified human acid alpha-glucosidase. , 1973, Birth defects original article series.

[39]  A. Engel,et al.  The spectrum and diagnosis of acid maltase deficiency , 1973, Neurology.

[40]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[41]  R. Lauer,et al.  Administration of a mixture of fungal glucosidases to a patient with type II glycogenosis (Pompe's disease). , 1968, Pediatrics.